89bio Inc. (ETNB)
89bio Statistics
Share Statistics
89bio has 145.98M shares outstanding. The number of shares has increased by 48.38% in one year.
| Shares Outstanding | 145.98M |
| Shares Change (YoY) | 48.38% |
| Shares Change (QoQ) | 24.16% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 140.33M |
| Failed to Deliver (FTD) Shares | 752 |
| FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 15.23M, so 10.43% of the outstanding shares have been sold short.
| Short Interest | 15.23M |
| Short % of Shares Out | 10.43% |
| Short % of Float | 12.44% |
| Short Ratio (days to cover) | 5.98 |
Valuation Ratios
The PE ratio is -2.23 and the forward PE ratio is -2.93. 89bio's PEG ratio is -0.03.
| PE Ratio | -2.23 |
| Forward PE | -2.93 |
| PS Ratio | 0 |
| Forward PS | 1.1 |
| PB Ratio | 2.04 |
| P/FCF Ratio | -2.23 |
| PEG Ratio | -0.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for 89bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.19, with a Debt / Equity ratio of 0.
| Current Ratio | 13.19 |
| Quick Ratio | 13.19 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 72.71 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-3.95M |
| Employee Count | 93 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -692K |
| Effective Tax Rate | 0.19% |
Stock Price Statistics
The stock price has increased by -31.76% in the last 52 weeks. The beta is 1.29, so 89bio's price volatility has been higher than the market average.
| Beta | 1.29 |
| 52-Week Price Change | -31.76% |
| 50-Day Moving Average | 8.4 |
| 200-Day Moving Average | 8.29 |
| Relative Strength Index (RSI) | 42.55 |
| Average Volume (20 Days) | 2.69M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -384.66M |
| Net Income | -367.08M |
| EBITDA | -384.66M |
| EBIT | -371.68M |
| Earnings Per Share (EPS) | -3.51 |
Balance Sheet
The company has 126.06M in cash and 1.82M in debt, giving a net cash position of 124.24M.
| Cash & Cash Equivalents | 126.06M |
| Total Debt | 1.82M |
| Net Cash | 124.24M |
| Retained Earnings | -824.51M |
| Total Assets | 478.69M |
| Working Capital | 440.32M |
Cash Flow
In the last 12 months, operating cash flow was -367.82M and capital expenditures -15K, giving a free cash flow of -367.84M.
| Operating Cash Flow | -367.82M |
| Capital Expenditures | -15K |
| Free Cash Flow | -367.84M |
| FCF Per Share | -3.51 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ETNB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ETNB is $29, which is 378.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $29 |
| Price Target Difference | 378.5% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
Scores
| Altman Z-Score | 2.86 |
| Piotroski F-Score | 0 |